Transformation of donor or destination vectors was done using Library Efficiency DB3.1 chemocompetent cells (Invitrogen).
LR Clonase (Invitrogen) was used to catalyze homologous recombination between the donor and destination vectors thus creating an expression plasmid for the ORF of interest.
Gateway recombinational cloning uses site-specific recombination to transfer cDNAs between donor and destination vectors, which requires additional specific sequences for recombination.
The variables included were co-morbid conditions, previous lower limb arthroplasty, the side and type of arthroplasty, and recovery details such as intra- and post-operative complications, donor blood, discharge destination and length of stay.
Water transfers also risk conveying invasive species from the donor basin to the destination.
Purified PCR products were cloned via pDONR201 donor vector (Invitrogen, Carlsbad, CA) into pKGWFS7 destination vector (VIB, Gent, Belgium; [ 38] to generate recombinant destination clones pMSP1, pMSP2 and pMSP3.
These coated vesicles, generated at donor compartments and then fused with the destination compartments, are enveloped by distinct sets of coats and are responsible for highly selective transport [9] [12].
The initial cloning reaction requires three major components: the GRIM destination vector, a linear miRNA donor, and BP Clonase™ enzyme, derived from lambda phage recombinases (Invitrogen™).
MAPK14/P38α cDNA was subsequently cloned by gateway recombination from the donor vector pCR-GW8 (Invitrogen) into pCMV-2×Myc destination vector described by Greggio et al (29).
Unesco has even printed up a snazzy brochure, with Babylon listed as the premier destination, to hand out to wealthy donors.
This donor construct was recombined with a Bra promoter containing destination vector to generate Bra > Myosin 10/11/14/9-myc.
